Even then, the amount of weight loss remains less clear and the evidence is still considered inconclusive
Often, the real problem is not the medicine itself, but inconsistent tracking of behavior and unclear feedback loops
273 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19), has caused a global acute respiratory disease pandemic
Nutrition, exercise, sleep, and lifestyle coaching are integrated into treatment
People who use Zepbound or Mounjaro, the dual-agonist medications, lose an average of about 20% of their body weight, while those who take Ozempic or Wegovy, the single-agonist drugs, lost an average of about 14% of their body weight
Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d